TargImmune Therapeutics

TargImmune Therapeutics is a biotechnology company focused in oncology using novel targeted onco-immunotherapies. The company's technology platform utilizes a non-viral vector to target and destroys cancer cells that over-express certain receptors while simultaneously eliciting an immune response against the cancer cells. It was founded in 2016 and is headquartered in Basel, Switzerland.